Document is current
Any future updates will be listed below
-
Authors
Li, Nan
Qin, Hao
Zhu, Fei https://orcid.org/0000-0002-1207-3675
Ding, Hao
Chen, Yang
Lin, Yixuan
Deng, Ronghui
Ma, Tianyu
Lv, Yuanyuan
Xiong, Changhao
Li, Rong
Wei, Yaohua
Shi, Jian
Chen, Hanqing
Zhao, Yuliang https://orcid.org/0000-0002-9586-9360
Zhou, Guangbiao
Guo, Hua
Lv, Mengyao
Lin, Yongfang
Han, Bing https://orcid.org/0000-0003-4584-1092
Nie, Guangjun https://orcid.org/0000-0001-5040-9793
Zhao, Ruifang https://orcid.org/0000-0002-2735-2159
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 1 November 2024
First Online: 27 December 2024
Competing interests
: The authors G.N., R.Z. and N.L. are inventors on a filed provisional application for China patent no. CN2024103159244 (An immune composition and its application) and no. CN2024113741833 (Tumour-shared surface antigen epitope peptide and its screening method), submitted by the National Center for Nanoscience and Technology, covering the potential application of tumour prevention of iPM nanovax. The authors declare no other competing interests.
